期刊文献+

甲型流感病毒HA基因核酸疫苗表达载体的构建及表达 被引量:2

Construction and Expression of Recombinant Plasmid Containing Influenza A Virus HA Gene
下载PDF
导出
摘要 目的构建含有甲型流感病毒HA基因的核酸疫苗表达载体,转染COS-7细胞,并检测目的蛋白的表达。方法将甲型流感病毒New Caledonia/20/99(H1N1)接种鸡胚后,收获尿囊液,提取流感病毒总RNA,RT-PCR法扩增HA基因。经亚克隆后获得质粒pMD-T/HA,酶切鉴定后测序,将其与质粒pVAX1分别双酶切后连接,构建甲型流感病毒表达载体pVAHA。脂质体法转染COS-7细胞,并检测目的蛋白的表达。结果扩增出1700 bp片段,与预期的HA基因大小相符,测序结果与GenBank报道一致,酶切鉴定表明甲型流感病毒表达载体pVAHA构建正确,Western blot检测证明了流感病毒HA蛋白的表达。结论已成功构建了甲型流感病毒HA基因核酸疫苗表达载体pVAHA。 Objective To construct a recombinant plasmid containing influenza A virus HA gene, transfect COS-7 cells and test for the expression of target protein. Methods Inoculate New Caledonia/20/99(HIHI )strain of influenza A virus to chick embryo, harvest the allantoic fluid and extract the total RNA of influenza A virus for amplification of HA gene by RT-PCR. Subclone the amplified HA gene to pMD18-T vector and identify the constructed recombinant plasmid pMD-T/HA by restriction analysis and sequencing. Digest plasmids pMD-T/HA and pVAX1 with Kpn I/BamH I separately, hnk the recovered HA gene and skeleton of pVAX1 ,and transform to E. coli XL 1-Blue to construct expression vector pVAHA. Transfect COS-7 cells with pVAHA in mediation of liposome and identify the expressed product by Western blot. Resuits The HA gene fragment at a length of 1700 bp was amplified, which was consistent with that expected. The sequence of amplified HA gene was identical to that reported in GenBank. Restriction analysis showed that expression vector pVAHA was constructed correctly. Western blot proved the expression of influenza A virus HA protein. Conclusion A recombinant plasmid as DNA vaccine, containing influenza A virus HA gene, was successfully constructed.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第2期133-135,共3页 Chinese Journal of Biologicals
关键词 甲型流感病毒 HA基因 核酸疫苗 表达载体 Influenza A virus HA gene DNA vaccine Expression vector
  • 相关文献

参考文献3

  • 1Tighe H, Corr M, Roman M, et al. C, ene vaccination: plasmid DNA is more than just a blueprint. Immunol Today, 1998,19(2) :87-89.
  • 2Ulmer J B. Influenza DNA Vaccines. Vaccine,2002,20(suppl)2:74-76.
  • 3戚凤春,盛军.流感疫苗的研究进展[J].中国生物制品学杂志,2004,17(3):190-192. 被引量:26

二级参考文献11

  • 1Chen Z, Matsuok, Asanumah, et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin-and neuraminidase-expressing DNAs. Vaccine, 1999,17(7-8) :653-659.
  • 2Levi R, Aboud-Pirok E A, Leclerc C, et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine, 1995,13:1353-1359.
  • 3John J T, Robert F B,Gale E S,et al. Evaluation of a recombinant Hemagglutinin expressed in insect cells as an influenza yaccinc in young and elderly adults. J Infect Dis, 1996,174:1467-1470.
  • 4Parkin N T, Chiu P, Coelingh K. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol, 1997,71: 2772-2778.
  • 5Hilbert A K, McCarthy L, Mills K H. Biodegradable microspheres containing influenza a vaccine Immune response in mice. Vaccine, 1999,17:1065-1073.
  • 6Robert B B. A review of attenuation of influenza virus by genetic manipulation. Am J Respir Crit Med, 1995,152:72-75.
  • 7Arnon R , Levi R. Synthetic reconbinant vaccines against viral agents. Int Arch Allergy Immunol, 1995,108: 321-326.
  • 8Harley V R, Mather K A,Power B E,et al. Characterization of an avian influenza virus nucleoprotein expressed in E. coli and in insect cells. Arch Virol, 1990,113: 267-277.
  • 9Mather H A, White J F, Hudson P J, et al. Expression of influenza neureminidase in baculovirus-infected cells. Virus Res, 1992,26:12715.
  • 10Lakey D L, Treanor J, Betts R F, et al. Recombinant Baculivirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis, 1996,174:838-841.

共引文献25

同被引文献18

  • 1刘玮红.核酸疫苗研究进展[J].泰山医学院学报,2006,27(2):182-184. 被引量:5
  • 2朱智勇,丁晓航,朱函坪,李岩金,陈学奎,沈吉友,张涛,何培江,姚苹苹,徐芳,翁景清,龚华岳,郭志军,苏波,孙淑滨,梁伟峰.人用H5N1禽流感疫苗免疫动物效果观察[J].中国公共卫生,2007,23(4):385-387. 被引量:5
  • 3Balicer RD, Huerta M, Levy Y, et al. Influenza outbreak control in confined settings [J]. Emerg Infect Dis, 2005, 11 (4): 579-583.
  • 4Palese P. Influenza: old and new threats [J]. Nat Med, 2004, 10 ( 12 Suppl) : S82-S87.
  • 5Dawood FS, Jain S, Finelli L, et all. Emergence of a novel swine- origin influenza A (H1N1)virus in humans [J]. N Engl J Med, 2009, 360 (25): 2605-2615.
  • 6Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic [J]. Nature, 2009, 459 (7250) : 1122-1125.
  • 7Sriram S, Palhan VB, Gopinathan KP. Heterologous promoter recognition leading to high-level expression of cloned foreign genes in Bombyx mori cell lines and larvae [J]. Gene, 1997, 190 (1):181-189.
  • 8Luckow VA, Summers MD. High level expression of nonthsed foreign genes with Autographa ealifomiea nuclear polyhedrosis virus expression vectors [J]. Virology, 1989, 170 ( 1 ): 31-39.
  • 9Quan FS, Vunnava A, Compans RW, et al. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice[J].PLoS One, 2010, 5 (2): e9161.
  • 10Barbic L,Madic J,Turk N,et al.Vaccine failure caused an outbreak of equine influenza in Croatia[J].Vet Microbiol,2009,133(1-2):164-171.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部